| http://www.w3.org/ns/prov#value | - Even as Merck and Pfizer and other Big Pharma companies concentrate on big acquisitions and more external collaborations as a way of getting better at drug development, Eli Lilly CEO John Lechleiter has focused on pushing the company's R&D arm to work faster and smarter
|
